Company Announcements In a March SEC filing, QIAGEN reported that it paid $68.2 million in cash, net of cash acquired, to purchase CLC bio (see IBO 10/31/13). N-of-One and BioDiscovery partnered to jointly market and sell N-of-One’s interpretation solutions and content with BioDiscovery’s genomic-analysis software. In April, N-of-One partnered with Syapse, which will offer access […]
Basel, Germany 6/2/14—Roche has acquired Genia Technologies, a developer of single-molecule DNA-sequencing technology, for $125 million in cash and up to $225 million in contingent payments. Genia’s platform employs semiconductor-based nanopore technology and is expected to reduce the price of sequencing. The platform allows for electrical real-time analysis without the need for complicated optics, labels, […]
Company Announcements Under a February partnership agreement, N-of-One and Appistry will jointly market and sell N-of-One’s interpretation services and content together with Appistry’s bioinformatics next-generation sequencing (NGS) analysis solutions and services. Sweden’s Science for Life Laboratory joined the Illumina Genome Network (IGN) in February, making it the 13th IGN partner and first IGN partner in […]
Company Announcements Sony announced in January the establishment with M3 of a new company, P5, which will launch a genomic-information platform in Japan for genome analysis services for research institutes and enterprises. It will also provide a service platform to support the use of genetic data for personalized medicine. Illumina is a minority investor. In […]
The American Association for Cancer Research (AACR) hosted its annual conference from April 5 to 9 in San Diego, California. Attendance for the conference was up 2% from last year, when it was held in Washington, DC, to over 18,400 attendees. The number of exhibitors rose 4% to 3,057. On Monday afternoon, the AACR/American Society […]
Hercules, CA 4/10/14; Cambridge, MA 4/10/14—Bio-Rad Laboratories, a provider of products for clinical diagnostics and life science research, has acquired Cambridge, Massachusetts–based GnuBIO, for an undisclosed amount. GnuBIO is the developer of a low-cost, droplet-based, integrated sequencing system that delivers results in hours rather than days. The instrument handles target selection, amplification, sequencing and informatics […]
At a time when large exhibitions seem to be declining in attendance and exhibitor participation, Analytica has clearly established itself as a “must-attend event” based on a proven formula for success. The trade fair took place May 10–13 in Munich, Germany. Held at an outstanding modern venue in the heart of Europe, well planned and […]
Company Announcements Life Technologies announced in January a multiyear license and supply agreement with Quest Diagnostics, giving Quest the right to develop molecular tests on the Ion Torrent platform. Illumina entered into a multiyear licensing agreement, giving Quest Diagnostics broad rights to its sequencing and genotyping technology for molecular lab–developed tests in the US and […]
Company Announcements Agilent Technologies is collaborating with Australia’s University of Queensland Centre for Clinical Research on oral cancer research. The Centre will use Agilent’s SureSelect target enrichment system. In December 2013, Appistry added new Broad Institute tools for next generation sequencing (NGS) analysis to its Cancer Genome Analysis Suite, including the ContEst tool for estimating […]
Company Announcements In October 2013, Roche certified the University of Liverpool’s Centre for Genomic Research as a provider of Roche NimbleGen SeqCap EZ Services. Knome raised $5.8 million in a debt offering, according to an October 2013 SEC filing. In November 2013, Maverix Biomics announced a strategic comarketing agreement with QIAGEN to streamline the interpretation […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
